Key Statistics for VRX
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (12/2013)
|Est. PEG Ratio
|Market Cap (M CAD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (USD)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for VRX
- Net Income (M/USD)
Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders, and distributes generic and branded generic drugs in Latin America and Eastern Europe.
More Company Profile & Key Executives for VRX
|J Michael Pearson "Mike"Chairman/CEO||Ari KellenGroup Chairman/Exec VP|
|Howard B SchillerExec VP/CFO||Robert R Chai-OnnExec VP/Secy/General Counsel|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.